Navigation Links
Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
Date:6/23/2011

reak down large chylomicron molecules, the accumulation of which, after intake of dietary fat, seems to be responsible for the occurrence of pancreatitis in LPLD patients. AMT is initiating study CT-AMT-011-04 to examine further how already treated patients handle chylomicrons over time. In addition, AMT will continue to collect follow up data on pancreatitis incidence. AMT's available funds will support its existing operations beyond the completion of the re-examination process into 2012.

"Based on communication from EMA, we understand that our technology platform using adeno-associated virus (AAV) vectors is approvable," Mr. Aldag added. "While we pursue the re-examination of Glybera, we will also continue development of other products in our pipeline such as hemophilia B and GDNF gene therapy for Parkinson's disease and Huntington's disease. We will also continue our preparations for registrations in Canada and the US."

For investors, AMT will conduct a conference call at 9:00 AM CET on June 24, 2011. To participate in the conference call, please call one of the following telephone numbers 15 minutes prior to the event, using access code 2788745: +44-(0)20-7136-2054 for the UK; +1-718-247-0881 for the US; and + 31-(0)20-201-5468 for the Netherlands. A pdf version of the presentation is available in the news and investor relations sections of the corporate website. Following the presentation, the lines will be opened for a question and answer session. A replay of the call will be available following the event.

About Glybera

AMT has developed Glybera as a treatment for patients with the genetic disorder lipoprotein lipase deficiency. LPLD is an orphan disease for which no treatment exists today. The disease is caused by mutations in the LPL gene, resulting in highly decreased or absent activity of LPL protein in patients. This protein is needed in order to break down large fat-carrying particles that circ
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Pharma and Food Thought Leaders Set to Converge in Amsterdam Next April 2011
2. Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
3. PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was
4. Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis
5. Data from Clinical Studies of bioTheranostics CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting
6. ImaginAb, Inc. Announces Availability of Custom Protein Radiolabeling Services for Molecular Imaging
7. Medco Partners With MolecularMD on Personalized Medicine Program for Chronic Myeloid Leukemia
8. The World Leader in Molecular Breast Imaging to Premiere Largest Detector in the Industry
9. Gen-Probe Files for US Regulatory Clearance of PANTHER™ System, Fully Automated and Integrated Molecular Testing Instrument
10. Latest Clinical Evidence Supports Promising Outlook for Low-Dose Molecular Breast Imaging (MBI)
11. Cepheid Extends Rapid Molecular Diagnostics Leadership with FDA Clearance of Xpert Clostridium difficile/Epi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... DENVER , June 18, 2013  Healthgrades, ... evaluate, compare and connect with physicians and hospitals, ... 2013: "Lean in" When Making Healthcare Decisions to ... the best performing hospitals for maternity care, gynecologic ... the treatment of women across 15 of the ...
(Date:6/18/2013)... RIDGE, N.J. , June 18, 2013  Pro ... Adrian Peterson and professional family expert Jo ... partnering with Mylan Specialty L.P., the fully integrated specialty ... ), to raise awareness of this significant health problem. ... the U.S. Food and Drug Administration (FDA) approval of ...
(Date:6/17/2013)... 17, 2013 Vanda Pharmaceuticals Inc. (Vanda) ... today at ENDO 2013, the Endocrine Society,s 95 ... entrain (synchronize) both melatonin and cortisol rhythms. This ... master body clock and address the circadian desynchrony ... SET (Safety and Efficacy of Tasimelteon) and RESET ...
Breaking Medicine Technology:Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 2Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 3Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 5Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 6Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 7Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 8Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4
... 2007 - Cytogen,Corporation (NASDAQ: CYTO) today reported ... 2007 Annual Meeting of the American,Association for ... Angeles,California April 14-18, 2007. The AACR abstracts ... approaches to drug,discovery and development embodied in ...
... DIEGO, March 29, 2007 /PRNewswire-FirstCall/ -- ... and,development company focused on commercializing proprietary ... and infectious diseases,announced today that results ... combination with intravenous 5-fluorouracil (5-FU),and capecitabine ...
Cached Medicine Technology:Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 2Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 3Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 4ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR Annual,Meeting 2ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR Annual,Meeting 3
(Date:6/18/2013)... Alto, CA (PRWEB) June 18, 2013 Palo ... be one of America's greenest cities with its recent major ... Council authorized three major solar electric power purchase agreements ... to 182,500 megawatt-hours (MWh) of solar photovoltaic electric power per ... the City’s electric needs. That’s enough power to supply ...
(Date:6/18/2013)... June 18, 2013 Internationally acclaimed ... new website, thebestbreast.com, showcasing his unique approach to ... information about his surgical method and highlights the ... on his website, Dr. Tebbetts compares his breast ... methods, Dr. Tebbetts’ method does not necessitate the ...
(Date:6/18/2013)... Researchers have discovered and mapped the signaling network between ... broken, could cut off cancer cell growth at its ... The University of Texas MD Anderson Cancer Center reported ... well-known cancer drug target, and MCM7, a protein vital ... June issue of Cancer Cell . , "MCM7 ...
(Date:6/18/2013)... June 18, 2013 myCNAjobs announces the ... free downloads, articles, and tips to the Caregiver Resources ... care for the 10,000+ retiring baby boomers each day, ... caregiver job resources has never been greater. ... job community, recently launched the first-ever free resource ...
(Date:6/18/2013)... Park City, UT (PRWEB) June 18, 2013 ... employees on Health Reimbursement Accounts . Zane Benefits, ... sponsored health benefits, is the leader in defined ... , According to Zane Benefits’ website, employees of a ... Account (HRA) may have questions about how Health Reimbursement ...
Breaking Medicine News(10 mins):Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 2Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 3Health News:Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website 2Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2Health News:Zane Benefits Publishes New Information on Health Reimbursement Accounts 2
... personal music players , , SATURDAY, Feb. 9 (HealthDay News) -- ... American youngsters have noise-induced hearing loss, something that,s entirely preventable, ... launched a public education campaign, called Turn it to the ... it can be prevented simply by turning down the volume ...
... (Nasdaq: AHPI ) reported today that its net income ... from $293,000 last year,or 4 cents per share, to about ... For the first half of the 2008 fiscal year ending ... last year, or six cents,per share, to about $93,500, or ...
... (Nasdaq:,EVVV), a global endovascular device company, today announced the,resignation ... Scientist and,from the company,s board of directors effective February ... people have shaped the treatment of,cardiovascular disease as much ... for improving the lives of patients worldwide," said,Jim Corbett, ...
... Mesa Laboratories,Inc. (Nasdaq: MLAB ) today ... regular quarterly cash dividend of ten cents per ... to shareholders of record at the close of,business ... acquires, manufactures and markets,electronic instruments for industrial, pharmaceutical ...
... profit margin increases; net loss ... remains stable - ... noted), BELLEVILLE, ON, Feb. 8 /PRNewswire-FirstCall/ - Bioniche Life Sciences,Inc. (TSX: ... second,quarter of its 2008 fiscal year, ending December 31, 2007., "The ...
... the Status Quo to Advance,Health Care Reform, ... the,Robert Wood Johnson Foundation,s State Coverage Initiatives program, ... outlines 2007 efforts to,expand health insurance coverage and ... the state level. While many states made progress, ...
Cached Medicine News:Health News:Campaign Targets Noise-Induced Hearing Loss in Kids 2Health News:Allied Healthcare's Net Suffers on Flat Sales, Performance Issues 2Health News:Allied Healthcare's Net Suffers on Flat Sales, Performance Issues 3Health News:Allied Healthcare's Net Suffers on Flat Sales, Performance Issues 4Health News:Allied Healthcare's Net Suffers on Flat Sales, Performance Issues 5Health News:Bioniche Reports Fiscal 2008 Second Quarter 2Health News:Bioniche Reports Fiscal 2008 Second Quarter 3Health News:Bioniche Reports Fiscal 2008 Second Quarter 4Health News:Bioniche Reports Fiscal 2008 Second Quarter 5Health News:Bioniche Reports Fiscal 2008 Second Quarter 6Health News:Bioniche Reports Fiscal 2008 Second Quarter 7Health News:Bioniche Reports Fiscal 2008 Second Quarter 8Health News:Bioniche Reports Fiscal 2008 Second Quarter 9Health News:Bioniche Reports Fiscal 2008 Second Quarter 10Health News:Bioniche Reports Fiscal 2008 Second Quarter 11Health News:Bioniche Reports Fiscal 2008 Second Quarter 12Health News:Bioniche Reports Fiscal 2008 Second Quarter 13Health News:Bioniche Reports Fiscal 2008 Second Quarter 14Health News:Report Lists Key Policy Questions Facing State, National Health Reform 2Health News:Report Lists Key Policy Questions Facing State, National Health Reform 3Health News:Report Lists Key Policy Questions Facing State, National Health Reform 4
... Be Set To Any Degree Interval For Marking ... Outer Diameter Opposing Radials Accommodate All Astigmatic Incisions., ... For AKs, LRIs Or Peripheral Corneal Incisions At ... Paired AKs, LRIs Or Peripheral Corneal Incisions 360 ...
... Unique Reversible Speculums Designed To ... By Flipping The Speculums Over, Allowing ... Palpebral Fissures To The Widest Possible ... Operation, Providing Unobstructed Around-The-Clock Access To ...
... The Forceps Are Available In Two Models: ... Are Compressed, The Jaws Close. The Other ... The Handles Are Compressed The Jaws Open., ,The ... To Be Inserted Through A 1.1mm Incision. These ...
... Allows Use Through A 1-Millimeter Incision.,Special ... Approach To The Incision.,Cystotome Tips Are ... Initiate And Complete A Circular Tear.,Titanium ... Improved Ergonomic Feel. Ideal For Bi-Manual ...
Medicine Products: